Short-term administration of small molecule phenamil induced a protracted osteogenic effect on osteoblast-like MC3T3-E1 cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 6, 2016, Pages 518-526

  Lo, Kevin W H ^a,b   Kan, Ho Man ^a   Laurencin, Cato T ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Biomaterials; Cell adhesion; Growth factors; Osteogenesis; Regenerative engineering; Small molecules

Indexed keywords

ALKALINITY; BIODEGRADABLE POLYMERS; CELL ENGINEERING; CELLS; MINERALOGY; MOLECULES; PHOSPHATASES; SCAFFOLDS (BIOLOGY);

CELLS ADHESION; GROWTH FACTOR; IN-VITRO; MC3T3-E1 CELL; MINERALISATION; OSTEOBLASTIC DIFFERENTIATION; OSTEOGENESIS; POLY LACTIC-CO-GLYCOLIC ACID; REGENERATIVE ENGINEERING; SMALL MOLECULES;

CELL ADHESION;

ALKALINE PHOSPHATASE; ALPHA5 INTEGRIN; CALCIUM; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FOCAL ADHESION KINASE 1; OSTEOPONTIN; PHENAMIL; POLYGLACTIN; AMILORIDE; DIFFERENTIATION ANTIGEN; DRUG CARRIER; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; METABOLISM;

AMILORIDE; ANIMALS; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELL LINE; DRUG CARRIERS; LACTIC ACID; MICE; OSTEOBLASTS; OSTEOGENESIS; POLYGLYCOLIC ACID;

EID: 84880733168     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1786     Document Type: Article

References (43)

1. Alves H, Dechering K, Van Blitterswijk C et al. 2011; High-throughput assay for the identification of compounds regulating osteogenic differentiation of human mesenchymal stromal cells. PLoS One 6: e26678.
2. Bessa PC, Casal M, Reis RL. 2008a; Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2: 81-96.
3. Bessa PC, Casal M, Reis RL. 2008b; Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2: 1-13.
4. Brey DM, Motlekar NA, Diamond SL et al. 2011; High-throughput screening of a small molecule library for promoters and inhibitors of mesenchymal stem cell osteogenic differentiation. Biotechnol Bioeng 108: 163-174.
5. Cary LA, Guan JL. 1999; Focal adhesion kinase in integrin-mediated signaling. Front Biosci 4: D102-113.
6. Cho MJ, Juliano R. 1996; Macromolecular versus small-molecule therapeutics: drug discovery, development and clinical considerations. Trends Biotechnol 14: 153-158.
7. Doorn J, Leusink M, Groen N et al. 2012; Diverse effects of cyclic AMP variants on osteogenic and adipogenic differentiation of human mesenchymal stromal cells. Tissue Eng Part A 18: 1431-1442.
8. Egusa H, Saeki M, Doi M et al. 2010; A small-molecule approach to bone regenerative medicine in dentistry. J Oral Biosci 52: 107-118.
9. El-Amin SF, Kofron MD, Attawia MA et al. 2004; Molecular regulation of osteoblasts for tissue engineered bone repair. Clin Orthop Relat Res 427: 220-225.
10. Giancotti FG, Ruoslahti E. 1999; Integrin signaling. Science 285: 1028-1032.
11. Guan JL. 1997; Role of focal adhesion kinase in integrin signaling. Int J Biochem Cell Biol 29: 1085-1096.
12. Hamidouche Z, Fromigue O, Ringe J et al. 2009; Priming integrin α5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc Natl Acad Sci USA 106: 18587-18591.
13. Han CY, Wang Y, Yu L et al. 2009; Small molecules with potent osteogenic-inducing activity in osteoblast cells. Bioorg Med Chem Lett 19: 1442-1445.
14. Johansson S, Svineng G, Wennerberg K et al. 1997; Fibronectin-integrin interactions. Front Biosci 2: d126-146.
15. Katagiri T, Yamaguchi A, Komaki M et al. 1994; Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127: 1755-1766.
16. Kumari A, Kumar V, Yadav SK. 2012; Plant extract synthesized PLA nanoparticles for controlled and sustained release of quercetin: a green approach. PLoS One 7: e41230.
17. Lieberman JR, Daluiski A, Einhorn TA. 2002; The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 84A: 1032-1044.
18. Lo KW-H, Ashe KM, Kan HM et al. 2012a; The role of small molecules in musculoskeletal regeneration. Regen Med 7: 1-15.
19. Lo KW-H, Kan HM, Ashe KM et al. 2012b; The small molecule PKA-selective cyclic AMP analogue as an inducer of osteoblast-like cell differentiation and mineralization. J Tissue Eng Regen Med 6: 40-48.
20. Lo KW-H, Ulery BD, Ashe KM et al. 2012c; Evaluating the feasibility of utilizing small molecule phenamil as a novel biofactor factor for bone regenerative engineering. J Tissue Eng Regen Med (Epub ahead of print; doi: 10.1002/term.1573).
21. Lo KW-H, Ulery BD, Ashe KM et al. 2012d; Studies of bone morphogenetic protein based surgical repair. Adv Drug Deliv Rev 64: 1277-1291.
22. Lo KW, Kan HM, Pfister KK. 2006; Identification of a novel region of cytoplasmic dynein intermediate chain important for dimerization in the absence of light chains. J Biol Chem 281: 9552-9559.
23. Lo KW, Ulery BD, Deng M et al. 2011a; Current patents on osteoinductive molecules for bone tissue engineering. Recent Patents Biomed Eng 4: 153-167.
24. Lo KW-H, Ashe KM, Kan HM et al. 2011b; Activation of cyclic AMP/protein kinase A signaling pathway enhances osteoblast cell adhesion on biomaterials for regenerative engineering. J Orthop Res 29: 602-608.
25. Malich G, Markovic B, Winder C. 1997; The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology 124: 179-192.
26. Marie PJ, Fromigue O. 2006; Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen Med 1: 539-548.
27. Marquis ME, Lord E, Bergeron E et al. 2009; Bone cells-biomaterials interactions. Front Biosci 14: 1023-1067.
28. Overman JR, Farre-Guasch E, Helder MN et al. 2013; Short (15minutes) bone morphogenetic protein-2 treatment stimulates osteogenic differentiation of human adipose stem cells seeded on calcium phosphate scaffolds in vitro. Tissue Eng Part A 19: 571-581.
29. Park KW, Waki H, Kim WK et al. 2009; The small molecule phenamil induces osteoblast differentiation and mineralization. Mol Cell Biol 29: 3905-3914.
30. Pittenger MF, Mackay AM, Beck SC et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
31. Pytela R, Pierschbacher MD, Ruoslahti E. 1985; Identification and isolation of a 140 kD cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 40: 191-198.
32. Quarles LD, Yohay DA, Lever LW et al. 1992; Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 7: 683-692.
33. Salasznyk RM, Klees RF, Williams WA et al. 2007; Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. Exp Cell Res 313: 22-37.
34. Sefcik LS, Petrie Aronin CE, Botchwey EA. 2008; Engineering vascularized tissues using natural and synthetic small molecules. Organogenesis 4: 215-227.
35. Shah AK, Lazatin J, Sinha RK et al. 1999; Mechanism of BMP-2 stimulated adhesion of osteoblastic cells to titanium alloy. Biol Cell 91: 131-142.
36. Siddappa R, Doorn J, Liu J et al. 2010; Timing, rather than the concentration of cyclic AMP, correlates to osteogenic differentiation of human mesenchymal stem cells. J Tissue Eng Regen Med 4: 356-365.
37. Siddappa R, Martens A, Doorn J et al. 2008; cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci USA 10: 7281-7286.
38. Sieg DJ, Hauck CR, Ilic D et al. 2000; FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2: 249-256.
39. Tintut Y, Parhami F, Bostrom K et al. 1998; cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. J Biol Chem 273: 7547-7553.
40. Weiss WA, Taylor SS, Shokat KM. 2007; Recognizing and exploiting differences between RNAi and small-molecule inhibitors. Nat Chem Biol 3: 739-744.
41. Widaa A, Claro T, Foster TJ et al. 2012; Staphylococcus aureus protein A plays a critical role in mediating bone destruction and bone loss in osteomyelitis. PLoS One 7: e40586.
42. Yamaguchi A, Katagiri T, Ikeda T et al. 1991; Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113: 681-687.
43. Young MF, Kerr JM, Ibaraki K et al. 1992; Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. Clin Orthop Relat Res 281: 275-294.